These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3474093)

  • 1. Enoxacin-warfarin interaction: pharmacokinetic and stereochemical aspects.
    Toon S; Hopkins KJ; Garstang FM; Aarons L; Sedman A; Rowland M
    Clin Pharmacol Ther; 1987 Jul; 42(1):33-41. PubMed ID: 3474093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man.
    Toon S; Hopkins KJ; Garstang FM; Rowland M
    Eur J Clin Pharmacol; 1987; 32(2):165-72. PubMed ID: 3582481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
    Lewis RJ; Trager WF; Chan KK; Breckenridge A; Orme M; Roland M; Schary W
    J Clin Invest; 1974 Jun; 53(6):1607-17. PubMed ID: 4830225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The warfarin-sulfinpyrazone interaction: stereochemical considerations.
    Toon S; Low LK; Gibaldi M; Trager WF; O'Reilly RA; Motley CH; Goulart DA
    Clin Pharmacol Ther; 1986 Jan; 39(1):15-24. PubMed ID: 3943265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective interaction between the R enantiomer of warfarin and cimetidine.
    Choonara IA; Cholerton S; Haynes BP; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1986 Mar; 21(3):271-7. PubMed ID: 2938614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of the warfarin-rifampin drug interaction in humans.
    Heimark LD; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Oct; 42(4):388-94. PubMed ID: 3665337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interaction between warfarin and enoxacin.
    McLeod AD; Burgess C
    N Z Med J; 1988 Apr; 101(844):216. PubMed ID: 3163107
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers.
    Wolf R; Eberl R; Dunky A; Mertz N; Chang T; Goulet JR; Latts J
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():63-9. PubMed ID: 6389476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of warfarin metabolism by diltiazem in humans.
    Abernethy DR; Kaminsky LS; Dickinson TH
    J Pharmacol Exp Ther; 1991 Apr; 257(1):411-5. PubMed ID: 2020000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans.
    O'Reilly RA; Trager WF; Rettie AE; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):290-4. PubMed ID: 3621782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of secobarbital with warfarin pseudoracemates.
    O'Reilly RA; Trager WF; Motley CH; Howald W
    Clin Pharmacol Ther; 1980 Aug; 28(2):187-95. PubMed ID: 7398186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of enoxacin in renal disease.
    Bury RW; Becker GJ; Kincaid-Smith PS; Moulds RF; Whitworth JA
    Clin Pharmacol Ther; 1987 Apr; 41(4):434-8. PubMed ID: 3470166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of warfarin and 7-hydroxywarfarin enantiomers by high-performance liquid chromatography with ultraviolet detection.
    Miura M; Okuyama S; Kato S; Kagaya H; Murata A; Komatsuda A; Wakui H; Sawada K
    Ther Drug Monit; 2011 Feb; 33(1):108-14. PubMed ID: 21157402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the relative sensitivities of factor VII and prothrombin time measurements in detecting drug interactions with warfarin.
    Pitsiu M; Parker EM; Aarons L; Holt B; Rowland M
    Eur J Clin Pharmacol; 1992; 42(6):645-9. PubMed ID: 1623906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.
    Banfield C; O'Reilly R; Chan E; Rowland M
    Br J Clin Pharmacol; 1983 Dec; 16(6):669-75. PubMed ID: 6661352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of the interaction between amiodarone and warfarin in humans.
    Heimark LD; Wienkers L; Kunze K; Gibaldi M; Eddy AC; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1992 Apr; 51(4):398-407. PubMed ID: 1563209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between theophylline and enoxacin.
    Takagi K; Hasegawa T; Yamaki K; Suzuki R; Watanabe T; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):288-92. PubMed ID: 3165968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):80-4. PubMed ID: 6491977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticrynafen-racemic warfarin interaction: hepatotoxic or stereoselective?
    O'Reilly RA
    Clin Pharmacol Ther; 1982 Sep; 32(3):356-61. PubMed ID: 7105625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.